The efficacy of combination of chemotherapy and immunotherapy compared with immunotherapy alone for NSCLC

被引：0
|
作者：
Hirano, Satoshi [1 ]
Takahashi, Hidekazu [1 ]
Hiroyuki, Amano [2 ]
Toshiaki, Inazaki [2 ]
Kuroki, Tsuguko [2 ]
Urano, Akira [2 ]
Kure, Fujihiro [2 ]
Fujita, Tetsuo [2 ]
Nakamura, Makoto [2 ]
Nakamura, Sukeyuki [2 ]
机构：
[1] Funabashi Municipal Med Ctr, Dept Med Oncol, Funabashi, Chiba, Japan
[2] Funabashi Municipal Med Ctr, Dept Resp Med, Funabashi, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P61-2
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [41] THE EFFICACY OF COMBINATION IMMUNOTHERAPY IN EXPERIMENTAL PSEUDOMONAS SEPSIS
    CROSS, AS
    OPAL, SM
    PALARDY, JE
    BODMER, MW
    SADOFF, JC
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 112 - 118
  • [42] THE EFFICACY OF COMBINATION IMMUNOTHERAPY IN EXPERIMENTAL PSEUDOMONAS SEPSIS
    CROSS, AS
    OPAL, SM
    PALARDY, JE
    BODMER, MW
    SADOFF, JC
    CLINICAL RESEARCH, 1991, 39 (02): : A214 - A214
  • [43] Concurrent, Sequential and Combination Immunotherapy Regimens in LA-NSCLC
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S17 - S18
  • [44] Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
    Zhang, Zhengfeng
    Wang, Dazhen
    Yang, Liu
    Zhao, Lu
    Yang, Lei
    Zhang, Jianji
    Lou, Changjie
    CANCER MEDICINE, 2023, 12 (14): : 15217 - 15228
  • [45] Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy
    Gui, Huan
    Nie, Yujie
    Yuan, Haohua
    Wang, Mengjiao
    Li, Linzhao
    Zhu, Lan
    Chen, Shuanghui
    Jing, Qianyu
    Wan, Quan
    Lv, Hang
    Nie, Yingjie
    Zhang, Xiangyan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [46] Immunotherapy alone or in combination with chemotherapy generates different MHC class I tumor phenotypes in mouse model
    Garrido-Lopez, Cristina
    Romero, Irene
    Enrique, Berruguilla
    Linares, Isabel
    Algarra, Ignacio
    Collado, Antonia
    Garcia-Lora, Angel M.
    Garrido, Federico
    TISSUE ANTIGENS, 2009, 73 (05): : 516 - 517
  • [47] Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy
    Dimitrakopoulos, F-I.
    Christopoulos, P.
    Elshiaty, M.
    Daniello, L.
    Pyrousis, I.
    Kottorou, A.
    Makatsoris, T.
    Kalofonos, H.
    Koutras, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S374 - S375
  • [48] A novel machine learning model for efficacy prediction of immunotherapy-chemotherapy in NSCLC based on CT radiomics
    Li C.
    Zhou Z.
    Hou L.
    Hu K.
    Wu Z.
    Xie Y.
    Ouyang J.
    Cai X.
    Computers in Biology and Medicine, 2024, 178
  • [49] Immunotherapy in Resectable NSCLC
    Forde, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S66 - S66
  • [50] The tsunami that is immunotherapy in NSCLC
    Charalambous, M.
    Weston, C.
    Khan, M.
    Khan, S.
    Ahmed, S.
    LUNG CANCER, 2019, 127 : S46 - S46
12345